Clinical Research Directory
Browse clinical research sites, groups, and studies.
The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study
Sponsor: Shanghai Zhongshan Hospital
Summary
The goal of the China Monoclonal Gammopathy Screening Project in First-degree Relatives of Patients With Multiple Myeloma (CHAPERONE) study is to assess the clinical significance of screening for monoclonal gammopathy (M-protein) in first-degree relatives of patients with multiple myeloma in China population, and establish a prospective cohort of individuals with monoclonal gammopathy of undetermined significance (MGUS), a precursor conditions to multiple myeloma. We will study these patients as a means to identify risk factors for progression to symptomatic multiple myeloma.
Official title: The China Monoclonal Gammopathy Screening Project in First-degree Relatives of Patients With Multiple Myeloma (CHAPERONE) --A Multicenter Observational Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
10000
Start Date
2023-07
Completion Date
2035-08
Last Updated
2023-08-01
Healthy Volunteers
No
Interventions
Sample of Blood
All participants will receive M-protein screening by serum electrophoresis. Individuals with detected M-protein will undergo further diagnostic tests to determine their accurate diagnosis. Patients with monoclonal gammopathy of undetermined significance (MGUS) would be carefully assessed and followed up.
Locations (1)
Zhongshan Hospital，Fudan University
Shanghai, Shanghai Municipality, China